» Authors » E G Papanikolaou

E G Papanikolaou

Explore the profile of E G Papanikolaou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 25
Citations 454
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Michos G, Najdecki R, Valasoulis G, Daponte A, Mamopoulos A, Papanikolaou E
Int J Surg Case Rep . 2025 Jan; 127:110832. PMID: 39778502
Introduction: Cervical pregnancy is a rare kind of ectopic pregnancy. Heterotopic pregnancy is a condition, where we have one sac in the uterus and one in another location, usually because...
2.
Asouhidou I, Sountoulides P, Papanikolaou E
Hippokratia . 2021 Jan; 24(2):95. PMID: 33488061
No abstract available.
3.
Papanikolaou E, Kyrou D, Zervakakou G, Paggou E, Humaidan P
J Assist Reprod Genet . 2013 Aug; 30(10):1341-5. PMID: 23949214
Purpose: A thin endometrium is one of the most difficult problems encountered in assisted reproduction every day practice. Whether a daily dose of 150 IU HCG for 7 days concomitant...
4.
Humaidan P, Polyzos N, Alsbjerg B, Erb K, Mikkelsen A, Elbaek H, et al.
Hum Reprod . 2013 Jun; 28(9):2511-21. PMID: 23753114
Study Question: Does a GnRH agonist (GnRHa) trigger followed by a bolus of 1.500 IU hCG in a group of patients at risk of ovarian hyperstimulation syndrome (OHSS) reduce the...
5.
Polyzos N, Zavos A, Valachis A, Dragamestianos C, Blockeel C, Stoop D, et al.
Hum Reprod Update . 2012 May; 18(4):393-404. PMID: 22544173
Background: Although several randomized controlled trials (RCTs) have examined the effect of misoprostol prior to hysteroscopy for cervical dilatation, no solid conclusion has been reached. We therefore set out to...
6.
Kyrou D, Al-Azemi M, Papanikolaou E, Donoso P, Tziomalos K, Devroey P, et al.
Eur J Obstet Gynecol Reprod Biol . 2012 Mar; 162(2):165-8. PMID: 22425288
Objective(s): To investigate the relationship between premature progesterone (P) rise and serum estradiol (E(2)) levels and the number of follicles in GnRH antagonist/rec-FSH stimulated cycles. Study Design: Two hundred and...
7.
Papanikolaou E, Pados G, Grimbizis G, Bili E, Kyriazi L, Polyzos N, et al.
Hum Reprod . 2012 Mar; 27(6):1822-8. PMID: 22422777
Background: In view of the current debate concerning possible differences in efficacy between the two GnRH analogues used in IVF stimulated cycles, the current study aimed to explore whether progesterone...
8.
Humaidan P, Papanikolaou E, Kyrou D, Alsbjerg B, Polyzos N, Devroey P, et al.
Reprod Biomed Online . 2011 Dec; 24(2):134-41. PMID: 22197130
In stimulated IVF/intracytoplasmic sperm injection cycles, the luteal phase is disrupted, necessitating luteal-phase supplementation. The most plausible reason behind this is the ovarian multifollicular development obtained after ovarian stimulation, resulting...
9.
Humaidan P, Kol S, Engmann L, Benadiva C, Papanikolaou E, Andersen C
Hum Reprod . 2011 Oct; 27(1):6-8. PMID: 22025229
Cochrane reviews are internationally recognized as the highest standard in evidence-based health care. A Cochrane analysis conducts systematic reviews of primary research in human health care, and the analysis includes...
10.
Humaidan P, Kol S, Papanikolaou E
Hum Reprod Update . 2011 Apr; 17(4):510-24. PMID: 21450755
Background: GnRH agonist (GnRHa) triggering has been shown to significantly reduce the occurrence of ovarian hyperstimulation syndrome (OHSS) compared with hCG triggering; however, initially a poor reproductive outcome was reported...